Sentinel lymph node mapping to reduce leg swelling after surgery
Treatments studied
Part of Cancer clinical trials.
This study tests whether a special way of finding lymph nodes during hysterectomy can lower the risk of long-term leg swelling or related dysfunction in people with stage I endometrial cancer. It compares standard lymph node assessment with sentinel lymph node mapping and looks at how this affects day-to-day leg functioning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’ve been diagnosed with endometrial cancer by biopsy and you’re planning a laparoscopic or robotic hysterectomy with lymph node assessment (biopsy within 90 days).
- Your cancer is stage I, and a recent checkup suggests it hasn’t spread to other areas.
- You’re age 18 or older and can take part with an activity level rated as 0–2 (able to do self-care and most daily activities).
- Your surgeon believes you can safely do pelvic lymph node removal (pelvic lymphadenectomy).
- You have no recent history of leg swelling/lymphedema, frequent leg infection (cellulitis), or a recent deep blood clot in the leg (within 90 days).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to check lymph nodes during surgery for early-stage endometrial (uterine) cancer: sentinel node biopsy versus removing more lymph nodes. It may help find whether the less extensive approach can stage the cancer accurately with fewer side effects.
This trial tests a “sentinel node” biopsy, using a special dye/tracer, during surgery for early-stage endometrial cancer. It may help doctors find whether cancer has spread to lymph nodes while possibly avoiding more extensive lymph node removal.
This trial tests whether removing only the first lymph node to detect cancer spread (sentinel node mapping) is as effective as removing all lymph nodes in the pelvic area (comprehensive lymphadenectomy) for a specific type of endometrial cancer with a p53 mutation, stages I–II. The goal is to see if the less extensive surgery can result in similar outcomes while possibly reducing side effects.
This trial studies how to find the “sentinel” (first) lymph node during surgery for high-risk endometrial (uterine) cancer. It may help surgeons better tell whether cancer has spread to nearby lymph nodes and guide the extent of lymph node removal.
This trial compares two ways to remove lymph nodes during hysterectomy for endometrial cancer that hasn't spread. The goal is to find which method works better with similar or fewer side effects.
This study looks at women with low-risk endometrial cancer who had tiny amounts of cancer cells found in their sentinel lymph nodes during surgery. Doctors want to see if it's safe to avoid additional treatments like chemotherapy or radiation.
Hear when a new Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.